Kao Corporation - 4452.T

4452.T Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
4452.T	0.3	-2.7	-10.2	-14.9	-14.4	1.5	2.9	-35.3	20.6	104.1
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 4452.T with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	4452.T
name	Kao Corporation
price	5847
changes percentage	0.2744
change	16
day low	5809
day high	5854
year high	7273
year low	5458
market cap	2715848688939
price avg 50	6389.64
price avg 200	6612.605
exchange	JPX
volume	1805000
avg volume	1334852
open	5811
previous close	5831
eps	177.49
pe	32.94
earnings announcement	2025-02-06T10:59:00.000+0000
shares outstanding	464485837
timestamp	2025-01-17 06:45:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 53.0%

Overall Quarterly Financial Health: 80.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	1532579000000	1551059000000	-1.19
gross profit	560427000000	548342000000	2.20
gross profit ratio	0.37	0.35	3.44
research and development expenses	62600000000	60601000000	3.30
operating expenses	496821000000	438271000000	13.36
interest income	4867000000	5650000000	-13.86
interest expense	3447000000	2418000000	42.56
ebitda	154497000000	205459000000	-24.80
ebitdaratio	0.1	0.13	-24.83
operating income	60035000000	110071000000	-45.46
operating income ratio	0.04	0.07	-44.80
net income	43870000000	86038000000	-49.01
net income ratio	0.03	0.06	-48.40
eps	94.37	183.28	-48.51

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,532,579 million in 2023 from 1,551,059 million in 2022 representing a change of -1.19%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 496,821 million in 2023 from 438,271 million in 2022 representing a change of 13.36%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 154,497 million in 2023 from 205,459 million in 2022 representing a change of -24.8%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 43,870 million in 2023 from 86,038 million in 2022 representing a change of -49.01%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 94.37 in 2023 from 94.37 in 2022 representing a change of -48.51%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 560,427 million in 2023 from 548,342 million in 2022 representing a change of 2.2%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 62,600 million in 2023 from 60,601 million in 2022 representing a change of 3.3%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 60,035 million in 2023 from 110,071 million in 2022 representing a change of -45.46%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	422191000000	365797000000	15.42
gross profit	159655000000	129906000000	22.90
gross profit ratio	0.38	0.36	6.48
research and development expenses	15320000000	16199000000	-5.43
operating expenses	122781000000	108347000000	13.32
interest income	4113000000	2518000000	63.34
interest expense	922000000	862000000	6.96
ebitda	62363000000	46567000000	33.92
ebitdaratio	0.15	0.12	23.86
operating income	36874000000	21559000000	71.04
operating income ratio	0.09	0.06	48.19
net income	26944000000	16470000000	63.59
net income ratio	0.06	0.05	41.74
eps	57.99	35.43	63.67

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 422,191 million in 2024Q2 from 365,797 million in 2024Q1 representing a change of 15.42%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 159,655 million in 2024Q2 from 129,906 million in 2024Q1 representing a change of 22.9%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 62,363 million in 2024Q2 from 46,567 million in 2024Q1 representing a change of 33.92%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 36,874 million in 2024Q2 from 21,559 million in 2024Q1 representing a change of 71.04%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 26,944 million in 2024Q2 from 16,470 million in 2024Q1 representing a change of 63.59%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 57.99 in 2024Q2 from 57.99 in 2024Q1 representing a change of 63.67%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 15,320 million in 2024Q2 from 16,199 million in 2024Q1 representing a change of -5.43%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 122,781 million in 2024Q2 from 108,347 million in 2024Q1 representing a change of 13.32%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1769746000000	1726350000000	2.51
total liabilities	757703000000	730966000000	3.66
total equity	1012043000000	995384000000	1.67
cash and cash equivalents	291663000000	268248000000	8.73
short term investments	6596000000	3605000000	82.97
long term investments	38688000000	32781000000	18.02
total current assets	817109000000	807206000000	1.23
total non current assets	952637000000	919144000000	3.64
total current liabilities	459934000000	486624000000	-5.48
total non current liabilities	297769000000	244342000000	21.87
common stock	85424000000	85424000000	0.00
retained earnings	711802000000	740374000000	-3.86
total debt	261072000000	262890000000	-0.69

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,769,746 million in 2023 from 1,726,350 million in 2022 representing a change of 2.51%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,012,043 million in 2023 from 995,384 million in 2022 representing a change of 1.67%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 291,663 million in 2023 from 268,248 million in 2022 representing a change of 8.73%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 6,596 million in 2023 from 3,605 million in 2022 representing a change of 82.97%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 817,109 million in 2023 from 807,206 million in 2022 representing a change of 1.23%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 459,934 million in 2023 from 486,624 million in 2022 representing a change of -5.48%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 261,072 million in 2023 from 262,890 million in 2022 representing a change of -0.69%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 757,703 million in 2023 from 730,966 million in 2022 representing a change of 3.66%. This indicates an increase in overall liabilities.

  Retained Earnings: Retained Earnings decreased to 711,802 million in 2023 from 740,374 million in 2022 representing a change of -3.86%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1847847000000	1771658000000	4.30
total liabilities	760720000000	744820000000	2.13
total equity	1087127000000	1026838000000	5.87
cash and cash equivalents	303979000000	253537000000	19.90
short term investments	0	8864000000	-100.00
long term investments	41899000000	39166000000	6.98
total current assets	868615000000	803073000000	8.16
total non current assets	979232000000	968585000000	1.10
total current liabilities	464232000000	450873000000	2.96
total non current liabilities	296488000000	293947000000	0.86
common stock	85424000000	85424000000	0.00
retained earnings	720551000000	693530000000	3.90
total debt	258880000000	271955000000	-4.81

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,847,847 million in 2024Q2 from 1,771,658 million in 2024Q1 representing a change of 4.3%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,087,127 million in 2024Q2 from 1,026,838 million in 2024Q1 representing a change of 5.87%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 303,979 million in 2024Q2 from 253,537 million in 2024Q1 representing a change of 19.9%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 868,615 million in 2024Q2 from 803,073 million in 2024Q1 representing a change of 8.16%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 720,551 million in 2024Q2 from 693,530 million in 2024Q1 representing a change of 3.9%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 258,880 million in 2024Q2 from 271,955 million in 2024Q1 representing a change of -4.81%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 760,720 million in 2024Q2 from 744,820 million in 2024Q1 representing a change of 2.13%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q2 from 8,864 million in 2024Q1 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 464,232 million in 2024Q2 from 450,873 million in 2024Q1 representing a change of 2.96%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	23415000000	-67821000000	134.52
operating cash flow	202481000000	130905000000	54.68
free cash flow	136034000000	53704000000	153.30
capital expenditure	-66447000000	-77201000000	13.93
depreciation and amortization	89595000000	89738000000	-0.16
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-19380000000	5496000000	-452.62
inventory	29383000000	-36930000000	179.56
acquisitions net	-40826000000	0	NaN
investments in property plant and equipment	-54166000000	-77201000000	29.84
net cash used for investing activites	-109302000000	-74911000000	-45.91
debt repayment	9553000000	-258000000	3802.71
common stock issued	0	0	NaN
common stock repurchased	-17000000	-50035000000	99.97
dividends paid	-69339000000	-68931000000	-0.59
net cash used provided by financing activities	-79983000000	-139311000000	42.59
cash at end of period	291663000000	268248000000	8.73
accounts receivables	20476000000	3394000000	503.30
cash at beginning of period	268248000000	336069000000	-20.18

Overall Score of Annual Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 23,415 million in 2023 from -67,821 million in 2022 representing a change of 134.52%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 202,481 million in 2023 from 130,905 million in 2022 representing a change of 54.68%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 136,034 million in 2023 from 53,704 million in 2022 representing a change of 153.3%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -66,447 million in 2023 from -77,201 million in 2022 representing a change of 13.93%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 19,380 million in 2023 from 5,496 million in 2022 representing a change of -452.62%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 20,476 in 2023 from 3,394 million in 2022 representing a change of 503.3%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -69,339 million in 2023 from -68,931 million in 2022 representing a change of -0.59%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	67911000000	-3769000000	1901.83
free cash flow	49634000000	-16183000000	406.70
capital expenditure	-18277000000	-12414000000	-47.23
depreciation and amortization	22293000000	22065000000	1.03
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-2958000000	7725000000	-138.29
accounts payables	1315000000	-12792000000	110.28
inventory	5554000000	-5905000000	194.06
acquisitions net	0	0	NaN
investments in property plant and equipment	-15957000000	-12414000000	-28.54
net cash used for investing activites	-7513000000	-13026000000	42.32
debt repayment	-11449000000	8174000000	-240.07
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-686000000	-34208000000	97.99
net cash used provided by financing activities	-21229000000	-31320000000	32.22
net change in cash	50442000000	-38126000000	232.30
cash at end of period	303979000000	253537000000	19.90
cash at beginning of period	253537000000	291663000000	-13.07

Overall Score of Quarterly Cashflow Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 50,442 million in 2024Q2 from -38,126 million in 2024Q1 representing a change of 232.3%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 67,911 million in 2024Q2 from -3,769 million in 2024Q1 representing a change of 1901.83%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 49,634 million in 2024Q2 from -16,183 million in 2024Q1 representing a change of 406.7%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -18,277 million in 2024Q2 from -12,414 million in 2024Q1 representing a change of -47.23%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1,315 million in 2024Q2 from 12,792 million in 2024Q1 representing a change of 110.28%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -2,958 million in 2024Q2 from 7,725 million in 2024Q1 representing a change of -138.29%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -686 million in 2024Q2 from -34,208 million in 2024Q1 representing a change of 97.99%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q3 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3296.9	3304.05	-0.22
net income per share	94.37	183.28	-48.51
operating cash flow per share	435.58	278.85	56.20
free cash flow per share	292.64	114.4	155.80
cash per share	641.62	579.1	10.80
book value per share	2177.12	2120.36	2.68
tangible book value per share	1530.37	1583.46	-3.35
shareholders equity per share	2116.06	2070.67	2.19
interest debt per share	569.04	565.16	0.69
market cap	2696153200000	2466917710000	9.29
enterprise value	2665562200000	2461559710000	8.29
pe ratio	61.46	28.67	114.34
price to sales ratio	1.76	1.59	10.61
pocfratio	13.32	18.85	-29.34
pfcf ratio	19.82	45.94	-56.85
pb ratio	2.74	2.54	8.00
ptb ratio	2.74	2.54	8.00
ev to sales	1.74	1.59	9.59
enterprise value over ebitda	17.25	11.98	44.01
ev to operating cash flow	13.16	18.8	-29.99
ev to free cash flow	19.59	45.84	-57.25
earnings yield	0.02	0.03	-53.35
free cash flow yield	0.05	0.02	131.77
debt to equity	0.27	0.27	-1.86
debt to assets	0.15	0.15	-3.13
net debt to ebitda	-0.2	-0.03	-659.27
current ratio	1.78	1.66	7.10
interest coverage	17.42	45.52	-61.74
income quality	4.62	1.13	308.46
dividend yield	0.03	0.03	-7.96
payout ratio	1.58	0.8	97.28
sales general and administrative to revenue	0.3	0.28	7.14
research and ddevelopement to revenue	0.04	0.04	4.54
intangibles to total assets	0.17	0.15	16.36
capex to operating cash flow	0.33	0.59	-44.36
capex to revenue	0.04	0.05	-12.89
capex to depreciation	0.74	0.86	-13.79
stock based compensation to revenue	0	0	NaN
graham number	2119.73	2922.14	-27.46
roic	0.03	0.06	-48.63
return on tangible assets	0.03	0.06	-48.83
graham net net	-340.08	-313.07	-8.63
working capital	357175000000	320582000000	11.41
tangible asset value	711399000000	743341000000	-4.30
net current asset value	59406000000	76240000000	-22.08
invested capital	1204634000000	1150579000000	4.70
average receivables	228269000000	223406500000	2.18
average payables	167054500000	164075500000	1.82
average inventory	271098500000	253226000000	7.06
days sales outstanding	53.81	54.27	-0.84
days payables outstanding	60.8	62.67	-2.99
days of inventory on hand	99.05	101.33	-2.25
receivables turnover	6.78	6.73	0.85
payables turnover	6.0	5.82	3.08
inventory turnover	3.68	3.6	2.31
roe	0.04	0.09	-49.61
capex per share	142.94	164.45	-13.08

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2023-12-31 from 0.09 on 2022-12-31, representing a change of -49.61%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 61.46 on 2023-12-31 from 28.67 on 2022-12-31, representing a change of 114.34%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.78 on 2023-12-31 from 1.66 on 2022-12-31, representing a change of 7.10%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.27 on 2023-12-31 from 0.27 on 2022-12-31, representing a change of -1.86%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
4452.T
calendar year	2024	2024	NaN
revenue per share	908.58	786.89	15.47
net income per share	57.99	35.43	63.66
operating cash flow per share	146.15	-8.11	1902.59
free cash flow per share	106.82	-34.81	406.83
cash per share	654.18	564.47	15.89
book value per share	2339.57	2208.89	5.92
tangible book value per share	1658.41	1546.24	7.25
shareholders equity per share	2272.6	2144.75	5.96
interest debt per share	559.11	586.87	-4.73
market cap	3006873099000	2679017945895	12.24
enterprise value	2961774099000	2697435945895	9.80
pe ratio	27.9	40.67	-31.39
price to sales ratio	7.12	7.32	-2.75
pocfratio	44.28	-710.8	106.23
pfcf ratio	60.58	-165.55	136.59
pb ratio	2.85	2.69	5.97
ptb ratio	2.85	2.69	5.97
ev to sales	7.02	7.37	-4.87
enterprise value over ebitda	47.49	57.93	-18.01
ev to operating cash flow	43.61	-715.69	106.09
ev to free cash flow	59.67	-166.68	135.80
earnings yield	0.01	0.01	45.76
free cash flow yield	0.02	-0.01	373.26
debt to equity	0.25	0.27	-10.12
debt to assets	0.14	0.15	-8.73
net debt to ebitda	-0.72	0.4	-282.84
current ratio	1.87	1.78	5.05
interest coverage	39.99	25.01	59.91
income quality	2.52	-0.23	1201.40
dividend yield	0.0	0.01	-98.21
payout ratio	0.03	2.08	-98.77
sales general and administrative to revenue	0.31	0.32	-2.54
research and ddevelopement to revenue	0.04	0.04	-18.06
intangibles to total assets	0.17	0.17	-1.49
capex to operating cash flow	0.27	-3.29	108.17
capex to revenue	0.04	0.03	27.56
capex to depreciation	0.82	0.56	45.72
stock based compensation to revenue	0	0	NaN
graham number	1721.92	1307.56	31.69
roic	0.02	0.01	67.26
return on tangible assets	0.02	0.01	56.36
graham net net	-293.98	-374.52	21.51
working capital	404383000000	352200000000	14.82
tangible asset value	770610000000	718795000000	7.21
net current asset value	107895000000	58253000000	85.22
invested capital	1275317000000	1216201000000	4.86
average receivables	233681500000	226236000000	3.29
average payables	236925000000	235196000000	0.74
average inventory	277935500000	270322500000	2.82
days sales outstanding	51.34	55.74	-7.89
days payables outstanding	81.92	89.61	-8.58
days of inventory on hand	95.66	105.62	-9.43
receivables turnover	1.75	1.61	8.57
payables turnover	1.1	1.0	9.39
inventory turnover	0.94	0.85	10.41
roe	0.03	0.02	54.46
capex per share	39.33	26.7	47.29

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 54.46%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 27.90 on 2024-06-30 Q2 from 40.67 on 2024-03-31 Q1, representing a change of -31.39%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.87 on 2024-06-30 Q2 from 1.78 on 2024-03-31 Q1, representing a change of 5.05%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.25 on 2024-06-30 Q2 from 0.27 on 2024-03-31 Q1, representing a change of -10.12%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 8086.86 which is higher than current price 5847, indicates the company may be undervalued.